Evidence map›Paper›PMID 29183686›Full record

ArticleNeuropharmacology2018

Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Kaveish Sewalia, Lucas R Watterson, Alyssa Hryciw, Anna Belloc, J Bryce Ortiz, M Foster Olive

Abstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kaveish SewaliaDepartment of Psychology, Arizona State University, Tempe, AZ, USA.
Lucas R WattersonDepartment of Psychology, Arizona State University, Tempe, AZ, USA.
Alyssa HryciwDepartment of Psychology, Arizona State University, Tempe, AZ, USA.
Anna BellocDepartment of Psychology, Arizona State University, Tempe, AZ, USA.
J Bryce OrtizDepartment of Psychology, Arizona State University, Tempe, AZ, USA.
M Foster OliveDepartment of Psychology, Arizona State University, Tempe, AZ, USA. Electronic address: foster.olive@asu.edu.
Arizona State University · US

Funding

Characterization and reversal of neurocognitive dysfunction produced by long-term synthetic cathinone useR01DA043172 · NIDA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI OLIVE, M. FOSTER · 2017 to 2021
$1.9M
mGluR5 antagonists for methamphetamine addictionR01DA025606 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OLIVE, M. FOSTER · 2009 to 2012
$1.2M
NIDA NIH HHS R01 DA025606NIDA NIH HHS R01 DA043172
6 · The paper itself

Abstract

Synthetic cathinones, frequently referred to as "bath salts", have significant abuse potential, and recent evidence suggests that these novel psychoactive substances can also produce cognitive deficits as well as cytotoxic effects. However, most of these latter findings have been obtained either using high concentrations in vitro or following non-contingent high dose administration in vivo. The present study utilized a model of long-term voluntary binge-like self-administration to determine potential detrimental effects of synthetic cathinones on cognitive function and their known underlying neural circuits, collectively referred to as neurocognitive dysfunction. Male Sprague-Dawley rats were allowed to self-administer the cocaine-like synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV, 0.03 mg/kg/infusion i.v.) in 96-hr sessions, or saline as a control. A total of five 96-hr sessions were conducted, each separated by 3 days of abstinence in the home cage. Three weeks following the last 96-hr session, animals underwent assessment of cognitive function using spatial object recognition (SOR) and novel object recognition (NOR) tasks, after which brains were harvested and assessed for neurodegeneration using FluoroJade C (FJC). Compared to animals self-administering saline, animals self-administering MDPV demonstrated (1) robust drug intake that escalated over time, (2) deficits in NOR but not SOR, and (3) neurodegeneration in the perirhinal and entorhinal cortices. These results indicate that repeated binge-like intake of MDPV can induce neurocognitive dysfunction. In addition, utilization of rodent models of extended binge-like intake may provide insight into potential mechanisms and/or approaches to prevent or reverse the detrimental effects of abused substances on cognitive and neurobiological functioning. This article is part of the Special Issue entitled 'Designer Drugs and Legal Highs.'

Indexed as

AnimalsBenzodioxolesBrainCognition DisordersConditioning, OperantDisease Models, AnimalDopamine Uptake InhibitorsFluoresceinsMaleNeuronsPyrrolidinesRatsRats, Sprague-DawleyRecognition, PsychologyReinforcement ScheduleSelf AdministrationBenzodioxolesDopamine Uptake InhibitorsFluoresceinsfluoro jadePyrrolidinesSynthetic CathinoneBingeEntorhinal cortexMDPVNeurodegenerationNovel object recognitionPerirhinal cortexPyrovaleroneSelf-administrationSpatial object recognitionSynthetic cathinone

Identifiers

PMID29183686
PMCPMC5966333
OpenAlexW2770121704

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.